文献速递皮肤肿瘤

PD-1H(VISTA)在皮肤鳞状细胞癌中的表达与T细胞浸润及活化的相关性

PD-1H (VISTA) Expression in Cutaneous Squamous Cell Carcinoma Is Correlated with T-Cell Infiltration and Activation.
PubMed 文献 · J Invest Dermatol · 2025-02-19

该研究对76例原发性皮肤鳞状细胞癌(cSCC)组织采用多重定量免疫荧光检测,发现VISTA表达于48%的cSCC、PD-L1表达于58%的cSCC;高VISTA表达(而非PD-L1)与更强的T细胞浸润和活化相关,且VISTA与PD-L1共表达无显著相关,提示不同肿瘤具有不同的免疫抑制微环境,为cSCC免疫治疗靶向VISTA提供依据。

要点

  • 48%的cSCC表达VISTA,58%表达PD-L1。
  • 高VISTA表达与更强的T细胞浸润和活化相关。
  • VISTA与PD-L1共表达无显著相关,提示免疫微环境异质性。

核心结论

  • VISTA在部分cSCC中表达,且高VISTA表达与更强的T细胞浸润和活化相关,支持在cSCC免疫治疗中靶向VISTA。

研究设计与样本

  • 研究采用多重定量免疫荧光检测76例原发性cSCC组织,分析VISTA与PD-L1表达及其与T细胞浸润活化的相关性。

主要发现

  • VISTA表达于48%的cSCC,PD-L1表达于58%的cSCC。
  • 高VISTA表达比PD-L1表达更与greater T-cell infiltration and activation相关,以增殖标志物Ki-67和细胞毒标志物颗粒酶B衡量。
  • 同一cSCC内VISTA与PD-L1共表达无显著相关。

临床怎么用

  • 结果提示VISTA或可作为cSCC免疫治疗的潜在靶点,并需注意不同肿瘤免疫抑制微环境的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cutaneous squamous cell carcinoma (cSCC) is one of the most common human cancers, with an estimated death rate approaching or exceeding that of melanoma. Immune inhibitory receptor antagonism through the blockade of PD-1 or its ligand, PD-L1, has revolutionized the treatment of cSCC; however, approximately half of patients still fail to respond. The inhibitory receptor PD-1H (also known as VISTA) controls T-cell and myeloid cell functions in preclinical cancer studies. Currently, cancer clinical trials using anti-VISTA-blocking antibodies are ongoing. We sought to determine the extent of VISTA expression in cSCCs and to correlate its expression with PD-L1 expression. Using multiplexed quantitative immunofluorescence of primary cSCC tissues (n = 76), we found that VISTA was expressed in 48% of cSCCs and that PD-L1 was expressed in 58% of cSCCs. We found that high VISTA expression, more than PD-L1 expression, correlated with greater T-cell infiltration and activation, as measured by the proliferation marker Ki-67 and the cytotoxic marker granzyme B. Furthermore, there was no significant correlation between VISTA and PD-L1 coexpression within the same cSCCs, suggesting that individual tumors have distinct immunosuppressive microenvironments. These findings provide a rationale for the targeting of VISTA in cSCC immunotherapy.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Kidacki M, Cho C, Lopez-Giraldez F, et al. PD-1H (VISTA) Expression in Cutaneous Squamous Cell Carcinoma Is Correlated with T-Cell Infiltration and Activation. J Invest Dermatol. 2025. PMID: 39983979. doi:10.1016/j.jid.2025.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。